{
    "organizations": [],
    "uuid": "c54ef390484c524bad1e35c89de45311f995a29c",
    "author": "Reuters Editorial",
    "url": "https://www.reuters.com/article/brief-gw-pharma-says-presenting-cbd-os-p/brief-gw-pharma-says-presenting-cbd-os-product-in-advisory-committee-meeting-with-fda-on-april-19-idUSFWN1RW0H2",
    "ord_in_thread": 0,
    "title": "BRIEF-GW Pharma Says Presenting CBD-OS Product In Advisory Committee Meeting With FDA On April 19",
    "locations": [],
    "highlightText": "",
    "language": "english",
    "persons": [],
    "text": "April 19 (Reuters) - GW Pharmaceuticals PLC:\n* GW PHARMACEUTICALS SAYS PRESENTING CBD-OS PRODUCT (EPIDIOLEX) IN ADVISORY COMMITTEE MEETING WITH FDA ON APRIL 19 - SEC FILING Source text: ( bit.ly/2HK1BW3 ) Further company coverage:\n ",
    "published": "2018-04-19T18:27:00.000+03:00",
    "crawled": "2018-04-20T12:11:05.003+03:00",
    "highlightTitle": "",
    "preprocessed_text": [
        "april",
        "reuters",
        "gw",
        "pharmaceutical",
        "plc",
        "gw",
        "pharmaceutical",
        "say",
        "presenting",
        "product",
        "epidiolex",
        "advisory",
        "committee",
        "meeting",
        "fda",
        "april",
        "sec",
        "filing",
        "source",
        "text",
        "company",
        "coverage"
    ]
}